Literature DB >> 19285642

Low-dose foscarnet preemptive therapy for cytomegalovirus viremia after haploidentical bone marrow transplantation.

Hengxiang Wang, Ling Zhu, Mei Xue, Jing Liu, Zikuan Guo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19285642     DOI： 10.1016/j.bbmt.2008.12.510

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  2 in total

1.  Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor.

Authors:  Maiko Asakura; Kazuhiro Ikegame; Satoshi Yoshihara; Shuichi Taniguchi; Takehiko Mori; Tetsuya Etoh; Akiyoshi Takami; Takashi Yoshida; Takahiro Fukuda; Kazuo Hatanaka; Heiwa Kanamori; Toshiaki Yujiri; Yoshiko Atsuta; Hisashi Sakamaki; Ritsuro Suzuki; Hiroyasu Ogawa
Journal:  Int J Hematol       Date:  2010-08-07       Impact factor: 2.490

Review 2.  Current Role of Prospective Monitoring and Preemptive and Prophylactic Therapy for Human Herpesvirus 6 After Allogeneic Stem Cell Transplantation.

Authors:  Guy Handley
Journal:  Open Forum Infect Dis       Date:  2022-08-03       Impact factor: 4.423
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.